Evertz Pharma

Evertz Pharma GmbH, headquartered in Frankfurt am Main, Germany, is a pharmaceutical company specializing in natural-based health and cosmetic products. Founded in 2017 by twin brothers Dominik and Tobias Evertz, it focuses on preventive healthcare through innovative formulations. Its business model emphasizes research-driven development of dietary supplements, ointments, and creams using natural ingredients, such as Rezilin for hair loss and Biovolen for anti-aging. Core operations involve producing high-quality products in facilities across Germany and Switzerland, serving markets in Germany, Austria, and Switzerland with a commitment to efficacy and sustainability.

The company pioneers a Bitcoin treasury strategy, holding Bitcoin as a primary reserve asset to diversify its financial portfolio and enhance long-term stability. This approach views Bitcoin as a hedge against inflation, complementing traditional reserves. Beyond treasury management, Evertz Pharma explores broader digital asset strategies, investigating blockchain applications to secure product traceability and enhance operational transparency, aligning with its innovative ethos in healthcare.

Led by Managing Director Dominik Evertz and CFO Tobias Evertz, the company maintains a strong presence in the pharmaceutical and cosmetics sectors through its focus on natural ingredients and partnerships with healthcare professionals. Its leadership drives a vision of integrating scientific innovation with financial resilience, positioning Evertz Pharma as a trailblazer in Germany’s health industry. By blending natural products with digital finance, the company ensures enduring relevance in global healthcare and decentralized economies.

Recent Developments